These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 207051)

  • 1. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The titration of clostridial toxoids and antisera in cell culture.
    Knight PA; Burnett C; Whitaker AM; Queminet J
    Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the methods of determining perfringens A antitoxin].
    Shemanova GF; Trapezov EV; Musina EE; Vlasova EV; Panteleev EI
    Biull Eksp Biol Med; 1983 Nov; 96(11):82-4. PubMed ID: 6315110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
    Reiss J; Wojtyła B; Lipko A
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay.
    Poxton IR; Byrne MD
    J Med Microbiol; 1984 Apr; 17(2):171-6. PubMed ID: 6323714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
    Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of in vitro methods for the potency testing of clostridial vaccines].
    Borrmann E; Schulze F; Diller R
    ALTEX; 2001; 18(1):34-6. PubMed ID: 11248848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the serodiagnostic reactions of the bacterium Clostridium butyricum strain CNRZ 528 using passive hemagglutination].
    Prösch S; Benedix A
    Allerg Immunol (Leipz); 1982; 28(4):260-71. PubMed ID: 6219561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.